FDA updates guidance on COVID-19 convalescent plasma

by on

FDA updates guidance on COVID-19 convalescent plasma
tjordan_drupal
Jan 20, 2021

The Food and Drug Administration yesterday updated its guidance and webpage on COVID-19 convalescent plasma.

The updates include recommendations on when individuals who have received an investigational COVID-19 vaccine qualify as convalescent plasma donors, and extend the period of enforcement discretion described in the guidance.

In addition, FDA yesterday posted updated information for blood establishments regarding the COVID-19 pandemic and blood donation. 

Headline

FDA updates guidance on COVID-19 convalescent plasma
tjordan_drupal
Jan 20, 2021

The Food and Drug Administration yesterday updated its guidance and webpage on COVID-19 convalescent plasma.

The updates include recommendations on when individuals who have received an investigational COVID-19 vaccine qualify as convalescent plasma donors, and extend the period of enforcement discretion described in the guidance.

In addition, FDA yesterday posted updated information for blood establishments regarding the COVID-19 pandemic and blood donation. 

COVID-19: Vaccines and Therapeutics
COVID-19: CDC, FDA and CMS Guidance
Novel Coronavirus (SARS-CoV-2/COVID-19)

Headline

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: